Keyword: Catalent Pharma Solutions

Catalent

Perceptions, Myths & New Thinking on Direct-to-Patient Clinical Supply

Direct-to-patient (DTP) distribution of clinical supplies provides trial sponsors with the opportunity to support improved recruitment and retention rates for their studies by removing or reducing the travel and time commitments that can otherwise inhibit patients’ willingness and ability to participate.
catalent_feb2019

Planning a Rapid Commercial Market Launch for Your Biologic

In this webinar, AstraZeneca and Catalent Biologics experts will share a case study on a 30-day commercial launch plan for a product into new markets and why this approach was important for patients.
catalent_casestudy

Overcoming Manufacturing Challenges for Accelerated Approvals

The pharmaceutical industry has experienced a trend in the number of accelerated approval designations for drugs (e.g. orphan drugs, breakthrough therapies, accelerated approvals, and FDA priority reviews) being developed.